Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Synthetic Genomics (SGI) and Integrated DNA Technologies (IDT) have entered into an agreement to manufacture, market, and commercialize small synthetic gene products.
Subscribe to our email newsletter
The companies have collaborated to construct custom, synthetic, double-stranded nucleic acids up to 5 kb.
As per the agreement, IDT will use oligonucleotide manufacturing expertise, including gBlocks Gene Fragments product line, in combination with SGI’s proprietary technologies to assemble small gene constructs.
The financial details of the agreement have not been disclosed.
SGI founder and CEO Craig Venter said they look forward to work with the market leader IDT in developing important products for the life sciences community.
IDT founder and CEO Joe Walder said they plan to apply SGI’s technologies to create affordable, efficient gene synthesis products that can be delivered quickly to the synthetic biology community.